What the Brand Says About How These Medications May Work The brand's materials describe semaglutide as a medication that "may work through the GLP-1 pathway" and tirzepatide as one that "may work through both GIP and GLP-1 pathways." Per the official website, GLP-1-based treatment "may be considered as part of a broader provider-guided care plan for weight care," and the brand frames weight care generally as involving "a range of factors, including appetite signaling, metabolism, and overall health history" - not a single mechanism or a guaranteed outcome
Many individuals hesitate to start injectable treatments due to fear or inconvenience
Unfortunately, NAD+ levels naturally decline with age, leaving you more prone to fatigue, a slower metabolism, and decreased resilience
When cytoplasmic concentrations of neurotransmitters rise dangerously high, TAAR1 activates G-protein-dependent signaling pathways that recruit intracellular kinases, including protein kinase C (PKC) and calcium/calmodulin-dependent protein kinase II (CaMKII) (Underhill et al., 2020)
Oral intake of ginger for chemotherapy-induced nausea and vomiting among women with breast cancer